ZA200508178B - A method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists - Google Patents

A method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists

Info

Publication number
ZA200508178B
ZA200508178B ZA200508178A ZA200508178A ZA200508178B ZA 200508178 B ZA200508178 B ZA 200508178B ZA 200508178 A ZA200508178 A ZA 200508178A ZA 200508178 A ZA200508178 A ZA 200508178A ZA 200508178 B ZA200508178 B ZA 200508178B
Authority
ZA
South Africa
Prior art keywords
humans
prevention
growth factor
hepatocyte growth
malaria infection
Prior art date
Application number
ZA200508178A
Other languages
English (en)
Inventor
Maria M Mota
Giordano Silvia
Rodriguez Ana
Rodrigues Margarida Cunha
Original Assignee
Inst Gulbenkian De Ciencia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Gulbenkian De Ciencia filed Critical Inst Gulbenkian De Ciencia
Publication of ZA200508178B publication Critical patent/ZA200508178B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
ZA200508178A 2003-03-12 2005-10-10 A method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists ZA200508178B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45348303P 2003-03-12 2003-03-12

Publications (1)

Publication Number Publication Date
ZA200508178B true ZA200508178B (en) 2007-04-25

Family

ID=32990777

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200508178A ZA200508178B (en) 2003-03-12 2005-10-10 A method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists

Country Status (8)

Country Link
US (1) US7670631B2 (ja)
EP (1) EP1601378A2 (ja)
JP (1) JP2007525428A (ja)
CN (1) CN1809382A (ja)
AP (1) AP2005003411A0 (ja)
BR (1) BRPI0408268A (ja)
WO (1) WO2004080420A2 (ja)
ZA (1) ZA200508178B (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0111872D0 (en) 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
US7968605B2 (en) 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
WO2003066067A2 (en) 2002-02-04 2003-08-14 Alfama - Investigaçao E Desenvolvimento De Produtos Farmaceuticos Lda. Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
GB2395432B (en) 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
CN1255106C (zh) * 2003-09-26 2006-05-10 李国桥 复方青蒿素
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
US7566465B2 (en) * 2006-12-21 2009-07-28 The United States Of America As Represented By The Secretary Of The Army Artemisinins in the clinical and veterinary management of kinetoplastid infections
WO2008147826A1 (en) * 2007-05-22 2008-12-04 Seattle Biomedical Research Institute Malaria liver stage drugs
CA2714121C (en) 2008-02-05 2016-03-22 Forskarpatent I Syd Ab Selection of rna-aptamers as anti-malaria agents
US20110092452A1 (en) * 2008-03-05 2011-04-21 The Regents Of The University Of Michigan Compositions and methods for diagnosing and treating pancreatic cancer
EP2470013A4 (en) 2009-08-27 2013-05-01 Us Health COMPOUNDS FOR THE TREATMENT OF MALARIA AND FOR PREVENTING MALARIA TRANSMISSIONS
FR2952823B1 (fr) * 2009-10-30 2012-04-20 Sanofi Aventis Utilisation de la ferroquine dans le traitement ou la prevention du paludisme
CA2782236A1 (en) * 2009-12-15 2011-06-23 Dec International Nz Limited Treatment composition and method
KR20130028058A (ko) * 2010-02-03 2013-03-18 엠이에이치 어소시에이츠, 인코포레이티드 선택적 및 생활성 동배체로서의 다수 치환된 플루오로메탄류
EP2404601A1 (en) * 2010-07-06 2012-01-11 BioAgency AG New drug combinations for the treatment of Malaria
WO2012135064A2 (en) * 2011-03-25 2012-10-04 The Regents Of The University Of California Attenuated strains of plasmodium
US9163044B2 (en) 2011-04-19 2015-10-20 Alfama, Inc. Carbon monoxide releasing molecules and uses thereof
JP6134710B2 (ja) 2011-07-21 2017-05-24 アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． 一酸化ルテニウム放出分子およびその使用
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
US20160151380A1 (en) * 2013-07-12 2016-06-02 The Regents Of The University Of California Therapies for diseases caused by arthropod-borne parasites
WO2015178940A1 (en) * 2014-05-20 2015-11-26 American University Of Cairo (Auc) Ligands that target plasmodium sporozoite binding sites on cd81 and therapeutic methods using them

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6344321B1 (en) 1990-06-11 2002-02-05 Gilead Sciences, Inc. Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met
US6214344B1 (en) 1995-06-02 2001-04-10 Genetech, Inc. Hepatocyte growth factor receptor antagonists and uses thereof
US6887499B2 (en) * 2000-05-22 2005-05-03 Enitan A. Bababunmi Formulation and method for treating skeletal muscle degeneration caused by malnutrition and disease

Also Published As

Publication number Publication date
CN1809382A (zh) 2006-07-26
BRPI0408268A (pt) 2006-03-07
WO2004080420A2 (en) 2004-09-23
US7670631B2 (en) 2010-03-02
AP2005003411A0 (en) 2005-12-31
JP2007525428A (ja) 2007-09-06
US20040185050A1 (en) 2004-09-23
EP1601378A2 (en) 2005-12-07
WO2004080420A3 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
ZA200508178B (en) A method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists
IL171145A (en) Method for the production of telmisartan
HK1072961A1 (en) A method of forming a nanocomposite coating.
EP1569515A4 (en) MALARIA vaccine method
IL175148A0 (en) Method for the production of fluoromethyl-substituted heterocycles
HK1078802A1 (en) Increasing the bioavailability of alendronate by predose administration alphacalcidol
IL180893A (en) Method for the preparation of a d-erythro-2,2-difluoro-2-deoxy-1-oxoribose derivative
PL375558A1 (en) A method of extending the dose range of vitamin d compounds
PT1753393T (pt) Procedimento de inoformulação de uma base galénica biocompatível
PL3001906T3 (pl) Sposób zapobiegania lub zwalczania zakażenia grzybami
AU2003299284A8 (en) Method for the production of a semiconductor component
HK1096398A1 (en) Method for the manufacture of thip thip
HK1075936A1 (en) Vaccine for the prevention of malaria
FI20021968A0 (fi) Menetelmä hiivojen kasvun estämiseksi
IL182395A0 (en) A method of forming a desiccating part
AU2003297044A8 (en) Method of forming sub-micron-size structures over a substrate
EP1556400A4 (en) PROCESS FOR THE PREPARATION OF 2-HALOGEN-2-DESOXYADENOSINE COMPOUNDS FROM 2-DESOXYGUANOSINE
ITUD20040054A1 (it) Procedimento per la realizzazione di un
ITBO20020602A1 (it) Apparecchiatura per la realizzazione di decori artistici,
EP1676578A4 (en) METHOD FOR STABILIZING DIARYLVINYLENE COMPOUND
IL174980A0 (en) Process for the preparation of a trifluoromethylthioether
ITBZ20030031A1 (it) Procedimento per la preparazione di un substrato
AU2003296459A1 (en) A set of building components for building a plurality of predefined structures
ITBO20010166A0 (it) Apparecchiatura per la movimentazione automatica di ante a battente
ITBO20020697A1 (it) Gruppo per la movimentazione verticale di strutture